You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API pexidartinib

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing pexidartinib

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Daiichi Sankyo Inc	TURALIO	pexidartinib	65597-402	CROSPOVIDONE	2038-07-24
Daiichi Sankyo Inc	TURALIO	pexidartinib	65597-402	FERRIC OXIDE YELLOW	2038-07-24
Daiichi Sankyo Inc	TURALIO	pexidartinib	65597-402	FERROSOFERRIC OXIDE	2038-07-24
Daiichi Sankyo Inc	TURALIO	pexidartinib	65597-402	HYPROMELLOSE	2038-07-24
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for pexidartinib

Excipient focus: CROSPOVIDONE

pexidartinib drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Daiichi Sankyo Inc	pexidartinib	65597-402
Daiichi Sankyo Inc	pexidartinib hydrochloride	65597-407
>Company	>Ingredient	>NDC

pexidartinib drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

pexidartinib drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Daiichi Sankyo Inc	pexidartinib	65597-402
Daiichi Sankyo Inc	pexidartinib hydrochloride	65597-407
>Company	>Ingredient	>NDC

pexidartinib drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERROSOFERRIC OXIDE

pexidartinib drug variants containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Daiichi Sankyo Inc	pexidartinib	65597-402
Daiichi Sankyo Inc	pexidartinib hydrochloride	65597-407
>Company	>Ingredient	>NDC

pexidartinib drug variants not containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

pexidartinib drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Daiichi Sankyo Inc	pexidartinib	65597-402
Daiichi Sankyo Inc	pexidartinib hydrochloride	65597-407
>Company	>Ingredient	>NDC

pexidartinib drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

pexidartinib drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Daiichi Sankyo Inc	pexidartinib	65597-402
Daiichi Sankyo Inc	pexidartinib hydrochloride	65597-407
>Company	>Ingredient	>NDC

pexidartinib drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

pexidartinib drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Daiichi Sankyo Inc	pexidartinib	65597-402
Daiichi Sankyo Inc	pexidartinib hydrochloride	65597-407
>Company	>Ingredient	>NDC

pexidartinib drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLOXAMER 407

pexidartinib drug variants containing POLOXAMER 407

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Daiichi Sankyo Inc	pexidartinib	65597-402
Daiichi Sankyo Inc	pexidartinib hydrochloride	65597-407
>Company	>Ingredient	>NDC

pexidartinib drug variants not containing POLOXAMER 407

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

pexidartinib drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Daiichi Sankyo Inc	pexidartinib	65597-402
Daiichi Sankyo Inc	pexidartinib hydrochloride	65597-407
>Company	>Ingredient	>NDC

pexidartinib drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.